[Prognostic factors in advanced ovarian cancer patients].
Terasawa
Katsuhiko
K
Department of Obstetrics and Gynecology, Sapporo Medical University.
Sagae
Satoru
S
D014408:Biomarkers, Tumor / Q000032:analysis; D018394:CA-125 Antigen / Q000032:analysis; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D007813:Laparotomy; D008207:Lymphatic Metastasis; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D010052:Ovariectomy / Q000379:methods; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies; D024162:Second-Look Surgery; D015996:Survival Rate; D013997:Time Factors
D014408:Biomarkers, Tumor; D018394:CA-125 Antigen